SCHEMBL11348122

SCHEMBL11348122

O=C(Nc1cccc(C(=O)Nc2c(O)ccc3cccc(S(=O)(=O)O)c23)c1)Nc1cccc(C(=O)Nc2c(O)ccc3cccc(S(=O)(=O)O)c23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.51
MEN1 O00255 4/20 0.51
RECQL P46063 4/20 0.51
HSD17B10 Q99714 4/20 0.51
TDP1 Q9NUW8 4/20 0.51
TIMP3 P35625 3/20 0.51
ALDH1A1 P00352 3/20 0.51
USP2 O75604 2/20 0.51
HPSE Q9Y251 5/20 0.45
MAPT P10636 3/20 0.45
PKM P14618 3/20 0.45
P2RX1 P51575 3/20 0.45
P2RX3 P56373 3/20 0.45
SIRT1 Q96EB6 2/20 0.45
ENPP3 O14638 1/20 0.45
ENTPD3 O75355 1/20 0.45
NR1I2 O75469 1/20 0.45
PRKD3 O94806 1/20 0.45
TDP2 O95551 1/20 0.45
CBX7 O95931 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10908963 0.93 MEN1 (0.43) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11341346 0.88 CD40 (0.52) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11433628 0.85 KDM4E (0.47) KMT2AMEN1HSD17B10ALDH1A1MAPT
SCHEMBL11352193 0.85 RECQL (0.60) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11344010 0.84 KMT2A (0.41) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11342918 0.83 KMT2A (0.54) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11341085 0.83 HPSE (0.43) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL11341158 0.82 RECQL (0.68) KMT2AMEN1RECQLHSD17B10TDP1
SCHEMBL10908064 0.81 CD40 (0.52) KMT2AMEN1TIMP3TOP1TTR
SCHEMBL11422168 0.81 RAB9A (0.55) KMT2AMEN1TDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed